MetaCap

Ocular Therapeutix Insider Trades

NASDAQ: OCULHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.53+0.02 (+0.27%)

Market open · Delayed 15 min · as of Oct 9, 9:41 AM ET

Last 12 months

Purchases
1 · $461.35K
Sales
23 · $2.60M
Shares bought / sold
60.23K / 292.88K
Net activity
Net selling $2.1 million

Ocular Therapeutix insider activity

Over the last 12 months, Ocular Therapeutix insiders reported 46 transactions on SEC Form 4: 1 open-market purchase and 23 sales. Insiders bought $461,354 and sold $2.6 million worth of stock, for net insider selling of $2.1 million. The largest seller was Dugel Pravin, with $1.7 million in reported sales.

The most recent filing shows Kaiser Peter (Chief Development Officer) selling 9,990 shares at $7.05 on Oct 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put OCUL's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

OCUL insider transactions

Ocular Therapeutix insider transactions
DateInsiderTypeSharesValueFiling
Oct 2, 2026Heier Jeffrey S.Chief Scientific OfficerSale10,869$76.63KForm 4
Oct 2, 2026Kaiser PeterChief Development OfficerSale9,990$70.43KForm 4
Aug 31, 2026Notman DonaldChief Operating OfficerSale1,099$11.25KForm 4
Aug 25, 2026Dugel PravinSee RemarksGift50,092—Form 4
Aug 25, 2026Dugel PravinSee RemarksGift50,092—Form 4
Aug 24, 2026Dugel PravinSee RemarksSale21,649$233.16KForm 4
Aug 24, 2026Heier Jeffrey S.Chief Scientific OfficerSale3,296$35.53KForm 4
Aug 24, 2026Nayak SanjayChief Strategy OfficerSale1,897$20.45KForm 4
Aug 24, 2026Kaiser PeterChief Development OfficerSale3,035$32.69KForm 4
Jun 16, 2026Dugel PravinSee RemarksGift50,092—Form 4
Jun 16, 2026Dugel PravinSee RemarksGift50,092—Form 4
Jun 10, 2026Williams Leslie J.DirectorAward14,000—Form 4
Jun 10, 2026RAINES MERILEEDirectorAward14,000—Form 4
Jun 10, 2026Hong Seung SuhDirectorAward14,000—Form 4
Jun 10, 2026Graves Adrienne LDirectorAward14,000—Form 4
Jun 10, 2026LINDSTROM RICHARD L MDDirectorAward14,000—Form 4
Jun 10, 2026Robins Jason ShandChief Financial OfficerAward15,441—Form 4
Jun 10, 2026Warden Charles MDirectorAward14,000—Form 4
Jun 3, 2026Waheed NadiaChief Medical OfficerSale14,828$122.63KForm 4
May 28, 2026Dugel PravinSee RemarksGift394,696—Form 4
May 28, 2026Dugel PravinSee RemarksGift394,696—Form 4
May 26, 2026Nayak SanjayChief Strategy OfficerSale1,858$15.24KForm 4
May 26, 2026Heier Jeffrey S.Chief Scientific OfficerSale3,018$24.75KForm 4
May 26, 2026Kaiser PeterChief Development OfficerSale2,967$24.33KForm 4
May 26, 2026Dugel PravinSee RemarksSale21,156$173.48KForm 4
Apr 9, 2026Dugel PravinSee RemarksGift394,696—Form 4
Apr 9, 2026Dugel PravinSee RemarksGift394,696—Form 4
Feb 23, 2026Nayak SanjayChief Strategy OfficerSale1,759$14.56KForm 4
Feb 23, 2026Kaiser PeterChief Development OfficerSale2,810$23.27KForm 4
Feb 23, 2026Dugel PravinSee RemarksSale20,056$166.06KForm 4
Feb 23, 2026Heier Jeffrey S.Chief Scientific OfficerSale3,057$25.31KForm 4
Feb 20, 2026LINDSTROM RICHARD L MDDirectorBuy60,229$461.35KForm 4
Feb 20, 2026Waheed NadiaChief Medical OfficerSale3,510$27.17KForm 4
Feb 12, 2026Waheed NadiaChief Medical OfficerSale7,863$71.08KForm 4
Feb 12, 2026Dugel PravinSee RemarksSale124,882$1.13MForm 4
Feb 12, 2026Nayak SanjayChief Strategy OfficerSale10,348$93.55KForm 4
Feb 12, 2026Notman DonaldChief Operating OfficerSale11,446$103.47KForm 4
Feb 4, 2026Notman DonaldChief Operating OfficerSale6,035$51.54KForm 4
Feb 2, 2026Notman DonaldChief Operating OfficerSale5,455$49.86KForm 4
Jan 21, 2026Robinson David WayneGlobal CCOAward136,000—Form 4
Jan 2, 2026Saroj NamrataChief Business OfficerAward79,112—Form 4
Jan 2, 2026Kaiser PeterChief Development OfficerAward79,112—Form 4
Jan 2, 2026Meyers Steve LawrenceChief Commercial OfficerAward64,900—Form 4
Jan 2, 2026Waheed NadiaChief Medical OfficerAward79,112—Form 4
Jan 2, 2026Anderman ToddChief Legal OfficerAward64,900—Form 4
Jan 2, 2026Nayak SanjayChief Strategy OfficerAward64,900—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related